Preclinical Gold Complexes as Oral Drug Candidates to Treat Leishmaniasis Are Potent Trypanothione Reductase Inhibitors.
Tunes LG, Morato RE, Garcia A, Schmitz V, Steindel M, Corrêa-Junior JD, Dos Santos HF, Frézard F, de Almeida MV, Silva H, Moretti NS, de Barros ALB, do Monte-Neto RL.
Tunes LG, et al.
ACS Infect Dis. 2020 May 8;6(5):1121-1139. doi: 10.1021/acsinfecdis.9b00505. Epub 2020 Apr 27.
ACS Infect Dis. 2020.
PMID: 32283915